God  our Guide CIDPUSA Foundation devoted to natural & alternative healing

 

 

 
Home
Diagnosis
Treatment
Pathology
Women Heart attack
Women risk diseases
Women stroke Risk
Services Page
Diet
Women ER delay
Inner Ear Disease
Women Killer Disease
Autoimmune diseases
Autoimmune E-Book
Personality
Hair & Chemicals

 
  Natural Makeup
  Neck Pain
  Ocular Female diseases
  Chronic fatigue syndrome
  Osteoporosis
  Women Heart Attacks
  Breast Size & Disease
  Female Sex Disease
  PARKINSON
  Memory problems
  Breast Lymph Drainage
  Kidney stone Buster
 Bras cause breast cancer
  Skin repair Clinic
 Pandas
  Hepatitis

Prevent Osteoporosis

  Some rheumatic disorders

  Alopecia treatment

Celiac disease Info

Small fiber neuropathy 

Depression and breast cancer

dermatomyositis

selenium

Backpain

Estrogen

UltraViolet

Iodine Deficiency

Heart solution

Animals

Anemia  Anger

Achalasia

Coconut oil  

Electrical Stimulation

   

                                  Lymes CIDP AND  Dangers

 

 autoimmune disease easily and permanently treatable please read our e-book

 

                      Lyme Dangers   Lyme & headache
 

Abstract: Return of muscle strength and function after use of intravenous immunoglobulin for Lyme disease-associated acute demyelinating polyneuropathy

CIDP SUPPORT GROUP

09-26-2003

Arch Phys Med Rehabil. 2003 Sep;84(9):E34-E35. Cynthia Majerske, MD (University of Pittsburgh, Pittsburgh, PA);

Patient: A 58-year-old man with babesiosis and Lyme disease.

Case Description: The patient, who had a history of splenectomy, was admitted with diffuse myalgias, fevers, and chills. He had a history of foreign and domestic travel 6 weeks prior. He was diagnosed with babesiosis.

The patient's muscle strength on admission was 5/5 throughout, but declined during his acute care stay. The patient was transferred to the acute rehabilitation floor, where he demonstrated noted weakness primarily in the lower extremities.

Through his first week of rehabilitation, he became significantly weaker in hip flexors and knee extensors (to 2+/5) as well as developed proximal upper-extremity weakness (to 3+/5) for shoulder flexion. An electromyogram (EMG) on day 14 showed primary demyelinating sensorimotor polyneuropathy. Sural nerve biopsy was unremarkable. Western blot for Lyme disease returned positive. He was started on intravenous Ceftriaxone, yet deterioration of muscle strength and function was noted.

An EMG on day 30 showed continued evidence of demyelinating polyneuropathy with significantly prolonged F-wave latencies in the upper extremities and moderate worsening in conduction velocities in 3 of 4 nerves. He was started on intravenous immunoglobulin (IVIG) on day 33 and received a total of 5 doses over 5 days.

Assessment/Results: Patient was discharged on day 38 with improving muscle strength and he was able to ambulate 150ft using a wheeled walker with supervision. At follow-up 8 weeks later, muscle strength had fully returned.

 

Discussion: This case illustrates that Lyme disease-associated demyelinating polyneuropathy may be treated with IVIG. The potential use of IVIG in this population is based on its efficacy in those with acute demyelinating neuropathy of alternative etiologies.

Conclusion: IVIG can be considered as a treatment option for demyelinating polyneuropathy associated with Lyme disease.

See how to get IVIg approved for Lyme

PMID: 13680780 [PubMed - as supplied by publisher]

 

 

continue to page-2 to learn how to become a superhuman

 

 

.
     
 
powered by cidpusa.org all rights reserved  Gods help for Humanity
 
   God reverses all diseases